Showing results (191-200 of 247) with videos related to

Sort By:
Pageof 25
European Urology|February 21, 2015
Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registryPhillip M Pierorazio, Michael H Johnson, Mark W Ball, et al.
Urology Practice|May 5, 2023
Promoting Organizational Change: A Urology Department-wide Wellness Program to Reduce BurnoutEzra J Margolin, Rashed L Kosber, Michael B Smigelski, et al.
The Journal of Urology|December 28, 2020
Outcomes of Active Surveillance for Young Patients with Small Renal Masses: Prospective Data from the DISSRM RegistryMeredith R Metcalf, Joseph G Cheaib, Michael J Biles, et al.
Oncology Research|February 6, 2004
Shifting gene expression profiles during ex vivo culture of renal tumor cells: implications for cancer immunotherapyFederica Moschella, Richard P Catanzaro, Brygida Bisikirska, et al.
Journal of Endourology|September 19, 2013
Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical marginsEdan Y Shapiro, Kyle Scarberry, Trushar Patel, et al.
The Journal of Urology|July 17, 2026
A Phase 2 Trial of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin for the Treatment of Non-Muscle-Invasive BCG Unresponsive Urothelial Carcinoma of the BladderG Joel DeCastro, Benjamin I Joffe, Mark N Stein, et al.
Urology|September 28, 2014
Who really benefits from nephron-sparing surgery?Solomon L Woldu, Aaron C Weinberg, Ruslan Korets, et al.
The Journal of Urology|July 5, 2014
Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failureJames M McKiernan, Dara D Holder, Rashed A Ghandour, et al.
The Journal of Urology|January 30, 2019
Selecting Patients with Small Renal Masses for Active Surveillance: A Domain Based Score from a Prospective Cohort StudyAyodeji E Sotimehin, Hiten D Patel, Ridwan Alam, et al.
Urologic Oncology|July 13, 2015
Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification toolsDanny Lascano, Jamie S Pak, Max Kates, et al.
Pageof 25